viral proteins / immunology*

Explore academic connections and research related to this keyword

258
Views
11
Total Connections
Search More Keywords

Related Articles & Bibliographies

1
Purified fusion protein vaccine protects against lower respiratory tract illness during respiratory syncytial virus season in children with cystic fibrosis
Piedra PA;Grace S;Jewell A;Spinelli S;Bunting D;Hogerman DA;Malinoski F;Hiatt PW;;
1996 the pediatric infectious disease journal 399 views
2
Respiratory syncytial virus (RSV) F, G, M2 (22K), and N proteins each induce resistance to RSV challenge, but resistance induced by M2 and N proteins is relatively short-lived
Connors M;Collins PL;Firestone CY;Murphy BR;;
1991 Journal of Virology 329 views
3
Monoclonal antibodies to respiratory syncytial virus proteins: identification of the fusion protein
Walsh EE;Hruska J;;
1983 Journal of Virology 320 views
4
Human cytotoxic T cells stimulated by antigen on dendritic cells recognize the N, SH, F, M, 22K, and 1b proteins of respiratory syncytial virus
Cherrie AH;Anderson K;Wertz GW;Openshaw PJ;;
1992 Journal of Virology 369 views
5
Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine
Murphy BR;Prince GA;Walsh EE;Kim HW;Parrott RH;Hemming VG;Rodriguez WJ;Chanock RM;;
1986 Journal of clinical microbiology 356 views
6
Cytotoxic T cell activity against the 22-kDa protein of human respiratory syncytial virus (RSV) is associated with a significant reduction in pulmonary RSV replication
Nicholas JA;Rubino KL;Levely ME;Meyer AL;Collins PL;;
1991 Virology 381 views
7
Safety and immunogenicity of a purified F protein respiratory syncytial virus (PFP-2) vaccine in seropositive children with bronchopulmonary dysplasia
Groothuis JR;King SJ;Hogerman DA;Paradiso PR;Simoes EA;;
1998 The Journal of infectious diseases 416 views
8
Effect of age and preexisting antibody on serum antibody response of infants and children to the F and G glycoproteins during respiratory syncytial virus infection
Murphy BR;Alling DW;Snyder MH;Walsh EE;Prince GA;Chanock RM;Hemming VG;Rodriguez WJ;Kim HW;Graham BS...
1986 Journal of clinical microbiology 274 views
9
Second-year surveillance of recipients of a respiratory syncytial virus (RSV) F protein subunit vaccine, PFP-1: evaluation of antibody persistence and possible disease enhancement
Tristram DA;Welliver RC;Hogerman DA;Hildreth SW;Paradiso P;;
1994 Vaccine 453 views
10
Human and murine cytotoxic T cells specific to respiratory syncytial virus recognize the viral nucleoprotein (N), but not the major glycoprotein (G), expressed by vaccinia virus recombinants
Bangham CR;Openshaw PJ;Ball LA;King AM;Wertz GW;Askonas BA;;
1986 journal of immunology (baltimore, md : 1950) 294 views
11
Immunogenicity and safety of respiratory syncytial virus subunit vaccine in seropositive children 18-36 months old
Tristram DA;Welliver RC;Mohar CK;Hogerman DA;Hildreth SW;Paradiso P;;
1993 The Journal of infectious diseases 318 views

Related Journals

No Journals Found

No journals are currently associated with this keyword.

Related Research Groups

No Research Groups Found

No research groups are currently associated with this keyword.

Explore Related Keywords

National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't Child Infant preschool Clinical Trial Randomized Controlled Trial Double-Blind Method placebos severity of illness index respiratory syncytial virus infections / immunology